PHARMAJET

About:

PharmaJet develops devices for fixed dose needle-free jet injection.

Website: http://www.pharmajet.com

Top Investors: United States Agency for International Development, National Institutes of Health, Rockies Venture Club, Stout Street Capital, 3Lines

Description:

PharmaJet is a user-friendly, inexpensive device for fluid injection into the body without a needle. Able to compete with traditional needle-syringe delivery, which inherently poses costly needle-stick, re-use, and pass-along disease risk, the technology creates a positive ROI back for every injection. Unique in the field of jet injection because of its ability to reach all target tissues (IM, SC--0.5 mL, and ID--0.1 mL) accurately and comfortably, supported by wide regulatory claims (global and country-specific) PharmaJet's platforms are the only commercially available devices that effectively address the 3 B annual immunization market. It was founded in 2005 and headquartered in Golden, Colorado.